# OnCo record mezigdomide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mezigdomide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mezigdomide" ;
  schema:name "Mezigdomide"@en ;
  schema:description "Mezigdomide is the most potent oral cereblon modulator, producing responses in about 40% of triple-class-refractory myeloma with dexamethasone alone."@en ;
  schema:url <https://onco.cc/drugs/mezigdomide/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=CC-92480> ;
  onco:status "phase-3" ;
  onco:modality "CELMoD (cereblon E3 ligase modulator)" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/>, <https://onco.cc/technologies/celmods/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:trials <https://onco.cc/trials/nct05519085/>, <https://onco.cc/trials/nct05552976/>, <https://onco.cc/trials/nct05372354/>, <https://onco.cc/trials/nct03989414/>, <https://onco.cc/trials/nct06988488/>, <https://onco.cc/trials/nct06892522/> .